IDO1 and neoplasm: Mechanistically, IDO-1 can trigger cell cycle arrest in the G1 phase or autophagy in T cells by activation of amino acid-sensitive kinase GCN2 and inhibition of the mTOR signaling pathway via tryptophan–kynurenine metabolic pathway in tumor microenvironment.